Premium Information is available for this item - Upgrade for $1 a day
6505-01-209-1874
Usp Diatrizoate Meglumine Injection
6505012091874 012091874 UROVIST CYSTO NDC50419-0196-30 019630
INC: 23817 Diatrizoate Meglumine Injection
January 2023
6
Marketplace 6505-01-209-1874
Request a Quotation from participating marketplace vendors
Related Documents 6505-01-209-1874 3+ Documents (More...)
RQST NE Updated Every Day 6505-01-209-1874 RQST Updated Every Day 6505-01-209-1874 RQST NE Related Documents
6505-01-209-1874 4+ Documents ( More... ) https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-209-1874
www.nsnlookup.com /fsg-53/fsc-5315/us 5315-01-039-9093 Headless Straight Pin 5315010399093010399093 1130-019630
Usp Diatrizoate Meglumine Injection www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-209-1874 https
https//www.nsnlookup.com /fsg-53/fsc-5331/us 5331-01-191-6068 O-Ring 5331011916068011916068,C100-019630
-5365/de 5365-12-194-4371 Plate Spacer 5365121944371 121944371 O-Ring 5331011916068011916068,C100-019630
Restrictions 6505-01-209-1874
6505-01-209-1874 is a Usp Diatrizoate Meglumine Injection that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. Demilitarization of this item has been confirmed and is not currently subject to changes. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item may be hazardous as it is in a Federal Supply Class for potentially hazardous items. A MSDS should be available from the supplier for the end user to evaluate any hazards. This item does not contain a precious metal.
Import and Export 6505-01-209-1874
- Schedule B
- Subscribe to View Schedule B
- HTS Code
- Subscribe to View HTS Code
End Users 6505-01-209-1874
- MOE Rule:
- V542
- Effective Date:
- 1 Apr 1991
Approved Sources 6505-01-209-1874
- Part Number
- Manufacturer
- Status
- NDC50419-0196-30
- Manufacturer
- 59463 - Bayer Healthcare Pharmaceuticals Inc (Active)
- Primary Buy
- Primary Buy
- 019630
- 59463 - Bayer Healthcare Pharmaceuticals Inc (Active)
- Primary Buy
- Primary Buy
- UROVIST CYSTO
- 59463 - Bayer Healthcare Pharmaceuticals Inc (Active)
- Incomplete Secondary Reference
- Incomplete Secondary Reference
Datasheet 6505-01-209-1874
- Characteristic
- Specifications
- FIIG
- Specifications
- A45100
- Active Medicament Medicinal Strength [AKJA]
- 30.000 Percentage, W/V Meglumine Diatrizoate Active Ingredient
- Pharmaceutical Vehicle Type [AKJQ]
- Aqueous
- Administration [CSGS]
- Retrograde Cystourethrography
- Primary Container Type [CQCT]
- Bottle With Rubber Stopper; Single Dose
- Primary Container Content Quantity [CRLK]
- 300.000 Milliliters
- Total Primary Container Quantity [CSCW]
- 8
- Special Features [FEAT]
- Bottle Has A Rated Capacity Of Not Less Than 500 Ml; Not Intended For Intravascular Injection
Management Data 6505-01-209-1874
- Effective Date
- Organization
- Unit of Issue
- Unit Price
- Qty Unit Pack
- Unit of Issue
- May 1985
- Veterans Administration (VA)
- BT
- Subscribe
- BT
- MOE
- USC
- Code
- Statement
- Order of Use
- Jump To Code
- Qty Per Assy
- UOM
- Technical Document
- Quantative Expression
- Code
- Veterans Administration (VA)
- V
- K
- U/I Contains 300 Ml
- 00000000300ML
- K
Similar Supply Items to 6505-01-209-1874
Freight Information 6505-01-209-1874
6505-01-209-1874 has freight characteristics.. 6505-01-209-1874 has a variance between NMFC and UFC when transported by rail and the description should be consulted.